Alprostadil treatment of early diabetic nephropathy
Jifeng Liu
Abstract
Jifeng Liu
Abstract
Objective Alprostadil treatment of early diabetic nephropathy.Methods In the control of blood glucose,blood pressure,blood lipid,anticoagulation,treatment of blood circulation,etc.Based on the treatment group received alprostadil 10 μg intravenous push,once a day,two weeks.Results 24 h urinary albumin treatment group decreased significantly(P0.01).Conclusion Intravenous alprostadil can delay the progression of diabetic nephropathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective Alprostadil treatment of early diabetic nephropathy.Methods In the control of blood glucose,blood pressure,blood lipid,anticoagulation,treatment of blood circulation,etc.Based on the treatment group received alprostadil 10 μg intravenous push,once a day,two weeks.Results 24 h urinary albumin treatment group decreased significantly(P0.01).Conclusion Intravenous alprostadil can delay the progression of diabetic nephropathy.
Key concepts: Medicine, Diabetic nephropathy, Urology, Blood pressure, Diabetes mellitus, Blood lipids, Nephropathy, Anesthesia